Characterization of a hemagglutinin-specific inhibitor of influenza A virus

Virology
G LuoM Krystal

Abstract

A novel inhibitor of influenza virus growth in tissue culture was identified and characterized. This compound (BMY-27709) has an IC50 of 3-8 microM for A/WSN/33 virus growth in a multicycle replication assay and is active against all H1 and H2 subtype viruses tested. However, BMY-27709 was found to be inactive against H3 subtype viruses, as well as influenza B/Lee/40 virus. BMY-27709 was also found to act against H1 and H2 viruses early in infection, suggesting that the target for inhibition is the hemagglutinin protein. This was confirmed through the use of reassortant viruses and the isolation of a virus resistant to BMY-27709. The resistant virus isolated contained a phenylalanine to serine change at amino acid 110 of the HA2 subunit. That this single mutation was responsible for the acquisition of resistance to BMY-27709 was proven through reverse genetics, as transfectant virus containing only this change was shown to be resistant to BMY-27709, while the control virus without this mutation remained sensitive. BMY-27709 is able to inhibit virus-induced red blood cell hemolysis, suggesting that it blocks the membrane fusion function of hemagglutinin. These experiments further illustrate that the hemagglutinin protein of infl...Continue Reading

Citations

Jan 27, 2004·Antimicrobial Agents and Chemotherapy·Christopher CianciMark Krystal
Mar 22, 2014·European Journal of Medicinal Chemistry·Fei YuDemin Zhou
Aug 31, 2001·Bioorganic & Medicinal Chemistry Letters·M S DeshpandeN A Meanwell
Jul 5, 2005·Expert Opinion on Investigational Drugs·C Cianci, M Krystal
Jul 13, 2012·Journal of Pharmaceutical Sciences·Alyssa M LarsonAlexander M Klibanov
May 7, 2013·European Journal of Medicinal Chemistry·Han WangDe-Min Zhou
Aug 31, 2000·Annual Review of Biochemistry·J J Skehel, D C Wiley
Dec 6, 2016·Expert Opinion on Investigational Drugs·Li-Yan ZengShuwen Liu
Jan 6, 1999·Antiviral Chemistry & Chemotherapy·S Shigeta
Sep 10, 1999·Antiviral Chemistry & Chemotherapy·J M ColacinoW G Laver
Nov 19, 2011·Antiviral Chemistry & Chemotherapy·Hongbing JiangTetsuya Toyoda
Jan 6, 2016·Antimicrobial Agents and Chemotherapy·Justyna CiejkaKrzysztof Pyrc
Dec 18, 2015·Journal of Virology·Kin Kui LaiRichard Yi Tsun Kao
Aug 31, 2020·The Journal of Membrane Biology·Gourab Prasad Pattnaik, Hirak Chakraborty
Jul 10, 2020·Journal of Drug Targeting·Jyoti VermaMaitreyi S Rajala
Jul 3, 2021·Pharmaceuticals·Zhaoyu ChenRuikun Du
May 15, 2013·Journal of Medicinal Chemistry·Fei YuDemin Zhou
Dec 9, 2017·Journal of Medicinal Chemistry·Rosana LeivaSantiago Vázquez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.